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Conceptual diagram presenting linear propagation of (gray) bands with varying
hydrophobicity. If this linear pattern is joined by fragments marked in red (initially
not fitting to linear propagation), the protein is at risk of undergoing amyloid
transformation.
If we accept the presented amyloid identification criteria as accurate, we
may apply them to predict the structures of various amyloidse including the
transthyretin amyloid. The structure of this protein is listed in PDB under ID
1DVQ [1], in its dimeric form, with each chain consisting of residues
10e124. Its structure is characterized as a mainly b-sandwich (CATH
code 2.60.40.180). Each b-sheet consists of four antiparallel b-strands. In
addition, a single helical fragment is also present (residues 74e81).
Fig. 12.1 illustrates the distributions of hydrophobicity (T, O and H) as it
appears in both chains treated as parts of dimer and as individual structural
units. The aim of Fig. 12.1 is to visualize the relation between T and O as
well as between O and H, with some fragments exhibiting strong alignment
between the observed and intrinsic distributions. The two chains appear
almost identical in terms of all three distributions.
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Thick dashed line at position 124 separates chain A (left) from chain B
(right). To reproduce the symmetry of the complex, results for chain B
are present in reverse order. Components of the appropriate b-sheets are
marked by red (starting strand 28e36, called also as II) and blue (starting
strand 11e19, called also as I) backgrounds.
Clearly, the structure lacks a prominent hydrophobic core (Fig. 12.1 and
Table 12.1). The RD (T-O-R) higher than 0.5 expresses the lack of centric
hydrophobic core. The RD (T-O-H) below 0.5 suggests not significant in-
fluence of intrinsic hydrophobicity. However the highest correlation coef-
ficient for HvO relation suggest the strong influence of intrinsic
hydrophobicity on the final distribution. The lack of centric hydrophobic
core seems to be caused mainly by the fragments at 60e80, 80e100 and
100e120 (Fig. 12.1). Additionally, as suggested by the arrangement of
b-strands, it appears that the initial b-strand at 11e19 (marked on
Fig. 12.1 by blue background) is closer to the theoretical distribution
whereas the strand at 28e36 (red background on Fig. 12.1) is more discor-
dant. This observation is supported by the parameters listed in Table 12.1,
where the b-sheet 28e36 (the starting fragment used to identify this sheet)
Fig. 12.1 Theoretical (T, blue) and observed (O, red) hydrophobicity distribution pro-
files for transthyretin dimer (1DVQ) chains A and B (A) treated as part of the dimer.
(B) treated as individual units.
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appears to be strongly dominated by the intrinsic hydrophobicity of its
component residues.
In search for fragments representing status recognized as amyloidogenic
(Chapter 10), the profile of correlation coefficients (for 5 aa window) is pre-
sented in Fig. 12.2. Based on the description and applicability of the fuzzy oil
drop model discussed in previous chapters, we may draw conclusions
regarding the propensity of the presented structures to undergo amyloid
transformation. This process is aided by identifying sections where the
observed distribution deviates from the theoretical distribution in specific
ways. We therefore calculate correlation coefficients for consecutive 5 aa
fragments (using an overlapping moving frame), seeking fragments which
exhibit low (preferably negative) values of HvT and TvO, coupled with
Table 12.1 Fuzzy oil drop parameters (RD values and correlation coefficients) for
transthyretin (1DVQ): dimer, chains treated as parts of dimer, chains treated as
individual units and b-sheets comprising the dimer (with status of b-strands as they
appear in those sheets). Values given in bold identify discordance (RD > 0.5) and
positions with large disproportion of correlation coefficient.
Trans thyretin
(1DVQ) Fragment RD Correlation coefficient
T-O-R T-O-H HvT TvO HvO
Dimer A þ B 0.650 0.467 0.222 0.368 0.722
Chain A in dimer 0.652 0.467 0.225 0.352 0.723
Chain B in dimer 0.648 0.468 0.220 0.380 0.720
Chain A individual 0.562 0.370 0.328 0.592 0.687
Chain B individual 0.556 0.368 0.317 0.591 0.687
b-strands
11e19 0.440 0.089 0.589 0.557 0.853
23e25 þ 53e55 0.411 0.343 0.682 0.602 0.751
104e112 0.148 0.184 0.677 0.910 0.586
115e123 0.639 0.697 0.054 0.576 0.568
b-sheet I 0.717 0.444 0.251 0.274 0.582
b-strands
28e36 0.467 0.171 0.468 0.489 0.872
40e49 0.517 0.216 0.713 0.155 0.533
67e73 0.760 0.182 L0.263 L0.549 0.898
91e97 0.776 0.704 L0.090 L0.423 0.897
b-sheet II 0.682 0.326 0.162 0.144 0.764
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high values of HvO. Fig. 12.2 shows the variability of correlation coeffi-
cients computed for each b-sheet in transthyretin.
Based on the chart shown in Fig. 12.2, the following fragments are seen
to fulfill all amyloid identification criteria: 34e45, 66e69, 73e75, 80e84,
89e93 and 98e102 (in each chain). To better visualize the structural spec-
ificity, the correlation coefficients limited to b-sheets following the spatial
localization of certain polypeptide chain fragments is shown in Fig. 12.3.
Ordering of residues is consistent with their respective placement in the
dimer (antiparallel arrangement). To avoid displaying multiple gaps between
the strands, results are conflated into contiguous sequences, hence no exact
numbering is marked on the horizontal axis.
Blue e HvO, red-TvO, green HvT.
Focusing the analysis on the status of b-sheets expressed by hydrophobic-
ity profile correlation coefficients provides an unobstructed view of differ-
ences between those fragments. In the presented diagram (Fig. 12.3),
amino acid sequences are ordered in accordance with the supersecondary
structure of the dimer (this particularly concerns the ordering of b-strands
in b-sheets). For this structure we calculate correlation coefficients using a
5 aa moving frame for b-sheets (treating them as the independent structural
unit). The results (Fig. 12.3) reveal significant variability of b-sheets which
make up the b-sandwich.
The sheet identified as “11e19” (I) does not appear to satisfy our amy-
loid identification criteria (Fig. 12.3B), whereas the sheet identified as
Fig. 12.2 Correlation coefficients between FOD hydrophobicity profiles calculated for
transthyretin dimer (1DVQ) in 5 aa overlapping moving frame mode: HvO e blue,
HvT e red, TvO e green. Thick dashed line at position 124 separates chain A
(left) from chain B (right). To reproduce the symmetry of the complex, results for chain
B are present in reverse order. This diagram enables us to identify amyloid transforma-
tion seeds (positions with disproportionally high HvO values vs. low HvT and TvO
values).
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“28e36” (II) reveals strong involvement of fragments in which the observed
distribution deviates from T in favor of H (Fig. 12.3A). Terminal residues
(i.e. the initial and final fragments shown in Fig. 12.3A) are generally accor-
dant with T. These residues correspond to the fragment at 40e49, which
occupies an outlying location in the b-sheet. The fragments at 67e73 and
91e97 exhibit nonuniform correlation coefficients, (central section in
Fig. 12.3A, showing negative values of HvT and TvO).
Assembling all the previously mentioned fragments (colored red in
Fig. 12.4) identifies part of the b-sheet which e according to FOD based
parameters e represents amyloid-like status. The loops (blue on Fig. 12.4)
do not exhibit linear propagation of bands of different hydrophobicity.
However if these two loops change their orientation versus the amyloid-
like fragment of b-sheet, and continue the profile making it similar to the
red fragment, the possible propagation in both directions appears to be
possible.
It can be surmised that the fragments identified in the analysis of charts
plotted in Fig. 12.3B act as amyloid seeds, since their spatial arrangement
is already characteristic of a linear pattern. When joined by additional frag-
ments (colored red) which do not belong to the b-sandwich, this pattern
Fig. 12.3 Correlation coefficients between FOD hydrophobicity profiles calculated for
b-sheets in transthyretin dimer (1DVQ) in 5-aa overlapping moving frame mode.
(A) profile for b-sheet I (starting fragment 11e19). (B) profile for b-sheet II (starting frag-
ment 28e36).
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spreads to the entire dimer. It also creates an open-ended structure which
may attach itself to similarly arranged fragments in another dimer (and so
on), ultimately producing a fibrillar structure. The structure illustrated in
Fig. 12.5 also clearly shows a twist, which is characteristic of a fibril. Addi-
tional units (in this case e dimers) are complexed at an angle, resulting in a
twisted structure.
Based on the presented correlation coefficients we may speculate that in
the amyloid form of transthryretin residues 40e49 along with the entire
fragment at 27e50 should adopt a linear structural pattern with other strands
comprising b-sheet II. Such arrangement (which, of course, calls for addi-
tional conformational changes) may provide the necessary conditions for
further propagation of the amyloid.
A similar structure, based on structural analysis of immunoglobulin light
chain domain VL (relatively easy to undergo the amyloid transformation),
has been proposed in Ref. [2]. While it differs somewhat to the one shown
above, it also demonstrates the necessary conditions for further linear prop-
agation in the event of certain rearrangements within the dimer. In this spe-
cific case, a bend in the fragment at 27e50 would enable it to align itself
with the planar b-structure, facilitating further propagation of the observed
discordance between T and O and preventing the dimer from forming a hy-
drophobic core.
Number of papers discussing transthyretin amyloid transformation is very
large [3e17]. Among them are many of experimental character. Some of
them discuss the possible therapeutic treatments [18e22].
Fig. 12.4 3D presentation of transthyretin dimer (1DVQ) from two angles. Red frag-
ments (67e73, 91e97, in each chain) express negative values of HvT and TvO, along
with strongly positive values of HvO. Fragments 27e50 in each chain (shown in
blue) are expected to undergo structural rearrangement in the process of amyloid
transformation, aligning themselves with the existing linear pattern exhibited by other
strands of b-sheet II.
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